Systematic lupus erythematosus and antiphospholipid syndrome during pregnancy;Systemischer lupus erythematodes und antiphospholipidsyndrome in der schwangerschaft

Zeitschrift fur Rheumatologie

Volumn 65, Issue 3, 2006, Pages 192-199

  Ruiz Irastorza, G ^a   Khamashta, M A ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Complications during pregnancy; Miscarriage; Neonatal lupus; Prophylaxis; SLE activity

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LABETALOL; METHOTREXATE; METHYLPREDNISOLONE; MIDESTEINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; PROSTACYCLIN DERIVATIVE; STEROID; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; CHILD GROWTH; CONGENITAL HEART BLOCK; DISEASE ACTIVITY; DISEASE CONTROL; HUMAN; MATERNAL HYPERTENSION; MEDICAL CARE; MORTALITY; NEWBORN DISEASE; OBSTETRIC CARE; PREGNANCY; PREGNANCY COMPLICATION; PROPHYLAXIS; PULMONARY HYPERTENSION; REVIEW; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS PREVENTION; WELLBEING;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS; THROMBOPHILIA;

EID: 33745135741     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-006-0058-z     Document Type: Review

References (45)

1. Bates S, Greer IA, Hirsh J, Ginsberg JS (2004) Use of antithrombotic agents during pregnancy. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126: 627S-644S
2. Baud O, Foix-L'Helias L, Kamisnski M et al. (1999) Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 341: 1190-1196
3. Bonnin M, Mercier FJ, Sitbon O et al. (2005) Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 102: 1133-1137
4. Branch DW, Khamashta MA (2003) Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol 101: 1333-1344
5. Branch DW, Peaceman AM, Druzin M et al. (2000) A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 182: 122-127
6. Brucato A, Frassi M, Franceschini F et al. (2001) Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 44: 1832-1835
7. Buyon JP, Kalunian KC, Ramsey-Goldman R et al. (1999) Assessing disease activity in SLE patients during pregnancy. Lupus 8: 677-684
8. Buyon JP, Rupel A, Clancy RM (2004) Neonatal lupus syndromes. Lupus 13: 705-712
9. Carmona F, Font J, Azulay M et al. (2001) Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis. Am J Reprod Immunol 46: 274-279
10. Carmona F, Font J, Moga I et al. (2005) Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol 53: 182-188
11. Cervera R, Piette JC, Font J et al. (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46: 1019-1027
12. Cowchock FS, Reece EA, Balaban D et al. (1992) Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin. Am J Obstet Gynecol 166: 1318-1323
13. Dekker GA, de Vries JI, Doelitzsch PM et al. (1995) Underlying disorders associated with severe early onset pre-eclampsia. Am J Obstet Gynecol 173: 1042-1048
14. 2Glycoprotein I. Arthrits Rheum 43: 140-150
15. Duckitt K, Harrington D (2005) Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. Br Med J 330: 565
16. Duley L, Henderson-Smart D, Knight M, King J (2001) Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. Br Med J 322: 329-333
17. Erkan D, Merririll JT, Yazici Y et al. (2001) High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 44: 1466-1467
18. Farquharson RG, Quenby S, Greaves M (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100: 408-413
19. Galie N, Manes A, Farahani KV et al. (2005) Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 14: 713-717
20. Girardi G, Redecha P, Salmon JE (2004) Heparin prevents antiphospholid antibody-induced fetal loss by inhibiting complement activation. Nature Med 10: 1222-1226
21. Hughes G (2004) The eradication of congenital heart block. Lupus 13: 489
22. Khamashta MA, Ruiz-Irastorza G, Hughes GRV (1997) Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 23: 15-30
23. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D et al. (1997) Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol 36: 772-777
24. Lima F, Khamashta MA, Buchanan NMM et al. (1996) A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 14: 131-136
25. Lockshin MD, Drunzin MI, Qamar T (1989) Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 160: 439-443
26. Lynch A, Silver R, Emlen W, Branch DW (1997) Antiphospholipid antibodies in healthy pregnant women. Rheum Dis Clin North Am 23: 55-70
27. McMillan E, Martin WL, Waugh J et al. (2002) Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome. Lupus 11: 392-328
28. Milne F, Redman C, Walker J et al. (2005) The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. Br Med J 330: 576-580
29. Nelson-Piercy C (1997) Hypertension and pre-eclampsia. In: Nelson-Piercy C (ed) Handbook of obstetric medicine. Isis medical media, Oxford, pp 1-16
30. Papageorghiou AT, Roberts N (2005) Uterine artery Doppler screening for adverse pregnancy outcome. Curr Opin Obstet Gynecol 17: 584-590
31. Pierangeli SS, Girardi G, Vega-Ostertag M et al. (2005) Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 52: 2120-2124
32. Rai R, Cohen H, Dave M, Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 314: 253-257
33. Ruiz-Irastorza G, Khamashta MA (2004) Evaluation of systemic lupus erythematosus activity during pregnancy. Lupus 13: 679-682
34. Ruiz-Irastorza G, Khamashta MA (2005) Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Ann N Y Acad Sci 1051: 606-612
35. Ruiz-Irastorza G, Lima F, Alves J et al. (1996) Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 35: 133-138
36. Ruiz-Irastorza G, Khamashta MA, Nelson-Piercy C, Hughes GRV (2001) Lupus pregnancy: is heparin a risk factor for osteoporosis? Lupus 10: 597-600
37. Ruiz-Irastorza G, Khamashta MA, Hughes GRV (2002 a) Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rev 1: 298-304
38. Ruiz-Irastorza G, Khamashta MA, Nelson-Piercy C, Hughes GRV (2002 b) Effects of lupus and antiphospholipid syndrome on pregnancy. Yearbook of Obstet Gynecol 10: 105-119
39. Ruiz-Irastorza G, Khamashta MA, Gordon C et al. (2004) Measuring systemic lupus erythematosus activity during pregnancy: validation of the Lupus Activity Index in Pregnancy scale. Arthritis Rheum (Arthritis Care & Research) 51: 78-82
40. Saaleb S, Copel J, Friedman D, Buyon JP (1999) Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody- associated congenital heart block. Arthritis Rheum 42: 2335-2345
41. Silver RK, MacGregor SN, Sholl JS et al. (1993) Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 169: 1411-1417
42. Silver RM, Porter TF, van Leeuween I et al. (1996) Anticardiolipin antibodies: clinical consequences of "low titers". Obstet Gynecol 87: 494-500
43. Stone S, Khamashta MA, Poston L (2001) Placentation, antiphospholipid syndrome and pregnancy outcome. Lupus 10: 67-74
44. Tincani A, Branch W, Levy RA et al. (2003) Treatment of pregnant patients with antiphospholipid syndrome. Lupus 12: 524-529
45. Triolo G, Ferrante A, Ciccia F et al. (2003) Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 48: 728-731